How to Invest in Janux Therapeutics?

Janux Therapeutics Investing Guide

  JANX
Before buying Janux Therapeutics stock, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Only after you clearly understand your investment objectives consider investing in Janux Therapeutics. To buy Janux Therapeutics stock, you can follow these steps:
  • Research Janux Therapeutics' stock before investing in Janux Therapeutics. It's a good idea to research the company and its stock by analyzing its financial statements, reading news articles, and studying its historical performance, including its growth strategy, change in net worth, competition, and potential risks.
  • Choose a brokerage firm to buy shares of Janux Therapeutics. We recommend well-established brokerages such as Charles Schwab, Fidelity, TD Ameritrade, and Robinhood, but in many ways, it will depend on your individual needs, preferences, and investment goals.
  • Open an account at one of the brokerages you have selected. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account. You will need to deposit funds into your brokerage account to purchase Janux Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order. Once you have located Janux Therapeutics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock.
It's important to note that investing in stocks such as Janux Therapeutics carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions regarding Janux Stock. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to invest safely in Janux Therapeutics.

Research Janux Therapeutics Stock

Researching Janux Therapeutics' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E).
About 93.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.83. Some equities with similar Price to Book (P/B) outperform the market in the long run. Janux Therapeutics recorded a loss per share of 1.28. The entity had not issued any dividends in recent years. Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager platform technology to treat patients suffering from cancer. The company was incorporated in 2017 and is headquartered in La Jolla, California. Janux Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people. To learn more about Janux Therapeutics call David Campbell at 858 751 4493 or check out https://www.januxrx.com.

Other things to consider when investing in Janux

Another important aspect of Janux Therapeutics' research is to evaluate the company's potential for future growth. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Janux Therapeutics' research are outlined below:
Janux Therapeutics generated a negative expected return over the last 90 days
Janux Therapeutics has high historical volatility and very poor performance
The company reported the previous year's revenue of 10.59 M. Net Loss for the year was (68.99 M) with loss before overhead, payroll, taxes, and interest of (57.8 M).
Janux Therapeutics currently holds about 338.76 M in cash with (43.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.15.
Over 93.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Diraimondo Thomas of 84000 shares of Janux Therapeutics at 53.24 subject to Rule 16b-3

Janux Therapeutics Quarterly Gross Profit

439,000

Check Janux Therapeutics' earnings reports

Janux Therapeutics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Janux Therapeutics. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Janux Therapeutics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Use historical earnings surprises to time your Janux Therapeutics position

Earnings surprises can significantly impact Janux Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Janux Therapeutics' investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-08-09
2022-06-30-0.37-0.41-0.0410 
2022-05-10
2022-03-31-0.37-0.320.0513 
2023-05-09
2023-03-31-0.49-0.420.0714 
2021-11-09
2021-09-30-0.18-0.26-0.0844 
2022-11-10
2022-09-30-0.49-0.40.0918 
2025-02-28
2024-12-31-0.4533-0.360.093320 
2023-08-08
2023-06-30-0.52-0.420.119 
2023-03-10
2022-12-31-0.49-0.390.120 

Know Janux Therapeutics' Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Janux Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Janux Therapeutics backward and forwards among themselves. Janux Therapeutics' institutional investor refers to the entity that pools money to purchase Janux Therapeutics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
State Street Corp2024-12-31
1.3 M
Lord, Abbett & Co Llc2024-12-31
1.3 M
Logos Global Management Lp2024-12-31
1.2 M
T. Rowe Price Associates, Inc.2024-12-31
1.1 M
Holocene Advisors, Lp2024-12-31
M
Perceptive Advisors Llc2024-12-31
817.9 K
Bank Of America Corp2024-12-31
794.8 K
Orbimed Advisors, Llc2024-12-31
758.6 K
Avidity Partners Management Lp2024-12-31
741.9 K
Ra Capital Management, Llc2024-12-31
10.4 M
Fmr Inc2024-12-31
8.7 M
Note, although Janux Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Janux Therapeutics' market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.88 B.

Market Cap

3.02 Billion

Evaluate Janux Therapeutics' profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.06)(0.07)
Return On Capital Employed(0.09)(0.09)
Return On Assets(0.06)(0.07)
Return On Equity(0.07)(0.06)
Determining Janux Therapeutics' profitability involves analyzing its financial statements and using various financial metrics to assess its ability to generate profits. Also, when deciding whether to invest in Janux Therapeutics, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Janux Therapeutics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Janux Therapeutics' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Janux Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Janux Therapeutics. Check Janux Therapeutics' Beneish M Score to see the likelihood of Janux Therapeutics' management manipulating its earnings.

Evaluate Janux Therapeutics' management efficiency

Janux Therapeutics has return on total asset (ROA) of (0.0857) % which means that it has lost $0.0857 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1009) %, meaning that it created substantial loss on money invested by shareholders. Janux Therapeutics' management efficiency ratios could be used to measure how well Janux Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.07 in 2025. Return On Capital Employed is likely to rise to -0.09 in 2025. At this time, Janux Therapeutics' Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 387.3 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 17.2 M in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 19.03  19.98 
Tangible Book Value Per Share 19.03  19.98 
Enterprise Value Over EBITDA(24.99)(26.24)
Price Book Value Ratio 2.81  2.95 
Enterprise Value Multiple(24.99)(26.24)
Price Fair Value 2.81  2.95 
Enterprise Value2.5 B2.6 B
Leadership effectiveness at Janux Therapeutics is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Beta
3.223

Basic technical analysis of Janux Stock

As of the 25th of March, Janux Therapeutics retains the Market Risk Adjusted Performance of (0.58), standard deviation of 4.1, and Risk Adjusted Performance of (0.19). Janux Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Check Janux Therapeutics' insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Janux Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Janux Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Janux Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Meyer Andrew Hollman 2 days ago
Acquisition by Meyer Andrew Hollman of 3334 shares of Janux Therapeutics at 4.21 subject to Rule 16b-3
 
Diraimondo Thomas over a week ago
Acquisition by Diraimondo Thomas of 84000 shares of Janux Therapeutics at 53.24 subject to Rule 16b-3
 
Ra Capital Management, L.p. over two weeks ago
Acquisition by Ra Capital Management, L.p. of 110206 shares of Janux Therapeutics at 31.02 subject to Rule 16b-3
 
Avalon Ventures Xi, L.p. over three weeks ago
Acquisition by Avalon Ventures Xi, L.p. of 2070 shares of Janux Therapeutics at 13.22 subject to Rule 16b-3
 
Zachariah Mciver over a month ago
Insider Trading
 
Avalon Ventures Xi, L.p. over a month ago
Disposition of 40803 shares by Avalon Ventures Xi, L.p. of Janux Therapeutics at 47.77 subject to Rule 16b-3
 
Meyer Andrew Hollman over a month ago
Disposition of 100 shares by Meyer Andrew Hollman of Janux Therapeutics at 43.6 subject to Rule 16b-3
 
Meyer Andrew Hollman over two months ago
Disposition of 5768 shares by Meyer Andrew Hollman of Janux Therapeutics at 54.5111 subject to Rule 16b-3
 
Meyer Andrew Hollman over two months ago
Acquisition by Meyer Andrew Hollman of 63000 shares of Janux Therapeutics at 53.24 subject to Rule 16b-3
 
Zachariah Mciver over two months ago
Insider Trading
 
David Campbell over three months ago
Disposition of 25000 shares by David Campbell of Janux Therapeutics at 56.1922 subject to Rule 16b-3
 
Meyer Andrew Hollman over three months ago
Acquisition by Meyer Andrew Hollman of 9880 shares of Janux Therapeutics at 20.24 subject to Rule 16b-3

Evaluate Janux Therapeutics' Outstanding Corporate Bonds

Janux Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Janux Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Janux bonds can be classified according to their maturity, which is the date when Janux Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Janux Therapeutics' technical indicators

Using predictive indicators to make investment decisions involves analyzing Janux Therapeutics' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Janux Therapeutics' intraday indicators

Janux Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Janux Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Janux Therapeutics Corporate Filings

10th of March 2025
Other Reports
ViewVerify
F4
7th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
27th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
14th of February 2025
Other Reports
ViewVerify
Janux Therapeutics time-series forecasting models is one of many Janux Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Janux Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Choose a brokerage platform to buy Janux Therapeutics' shares

In investing, finding the right broker is a crucial step for anyone looking to embark on a journey into the stock market. It all begins with a thorough comparison of costs and fees, as low-cost or commission-free brokers can significantly impact an investor's returns. However, the cheapest option is not always the best choice. The adventure continues with exploring various trading platforms, seeking one that is user-friendly, reliable, and functional. The ideal platform will provide the necessary research, analysis, and investment monitoring tools. As the quest goes on, it's essential to consider the different account types brokers offer, such as individual, joint, and retirement accounts. In addition, for those interested in trading on margin, brokers offering margin accounts should also be considered. The journey leads to the discovery of brokers that provide a wide range of investment options, including stocks, bonds, ETFs, and mutual funds. This diversity allows investors to build well-rounded portfolios that suit their needs and goals.
Customer service is another crucial factor in this decision-making process. The perfect broker would have a responsive, knowledgeable, and available customer support team ready to assist with various issues or investment decisions. Aspiring investors should seek brokers with quality research, market analysis, and educational resources. These tools are essential for making informed decisions and improving investment knowledge. It's also vital to ensure that the broker is regulated by an appropriate regulatory body and has robust security measures to protect personal and financial information. Additionally, account minimums and funding options should be taken into consideration. A broker with flexible account minimums and various funding options, such as wire transfers, ACH transfers, or check deposits, will cater to different investor needs. A seamless mobile and web experience is a must in today's fast-paced world. The ideal broker will allow investors to manage their investments easily on the go.
Finally, it is essential to consider various brokers' reviews and conduct reputation analysis. By reading online assessments and seeking recommendations, valuable insights into each broker's reputation can be gathered. After a thorough investigation, you can find a broker that checks all the boxes and aligns with their preferences and requirements regarding taking a position in Janux Therapeutics.

Open brokerage account to buy Janux Stock

Once you've selected a broker, visit their website or a local branch to initiate the account-opening process. Most brokers offer online account opening, which is typically faster and more convenient. When you begin the process, you'll need to select the type of account you want to open. This may include individual, joint, or retirement accounts. Some brokers may also offer margin accounts, which allow you to trade on margin. Next, you'll need to complete the application form.
Whether you're filling out an online or paper application, you'll need to provide personal information, such as your name, address, Social Security Number or other tax identification number, date of birth, and employment information. You may also be asked about your investment experience, financial situation, and goals. After completing the application form, review it carefully for accuracy and submit it to the broker. Some brokers may require you to provide additional documentation, such as a copy of your driver's license or passport, for identity verification. Once your application is submitted, the broker will review it and may run a background check or verify your credit history. You'll receive an email or notification with your new brokerage account details if your application is approved.

Fund your account to invest in Janux Stock

Once your account is open, you can fund it by linking your bank account to your brokerage account. To do this, log in to your brokerage account and look for an option to add or link a bank account. You will need to provide your bank account number and the routing number for your bank. This information can be found on your checks or by contacting your bank. After linking your bank account, you can initiate a transfer of funds from your bank account to your brokerage account. This process may vary depending on the brokerage, but generally, you will need to navigate to the funding or deposit section of the brokerage website or app. From there, you can choose the linked bank account and enter the amount you wish to transfer. Keep in mind that there may be limits on the amount you can transfer in a single transaction, and the transfer may take several business days to complete.
Some brokerages also offer other funding options, such as wire transfers, mailing a check, or transferring assets from another brokerage. If you prefer to use one of these methods, check with your brokerage firm for specific instructions. Once the funds are in your brokerage account, you can use them to purchase investments such as stocks, bonds, mutual funds, or other financial instruments.

Place your Janux Stock order

Placing a Janux Therapeutics purchase order involves providing instructions to your selected brokerage firm to aquare shares of Janux Therapeutics on your behalf. First, your will need to access your brokerage account through their website or mobile app using your login credentials. Make sure you have sufficient funds in your account to cover the cost of the stock purchase, including any applicable fees or commissions. Once you are logged in, locate the trading platform or order entry section within the brokerage interface. It may be labeled as "Trade," "Order Entry," or something similar. Next, you will need to provide the necessary information to place your stock order. This typically includes: .
TickerEnter the ticker symbol, which is the unique series of letters representing the stock, e.g., JANX for Janux Therapeutics
TypeChoose the type of order you want to place. The most common order types are market orders, limit orders, stop orders, and stop-limit orders. Each order type has its own advantages and drawbacks, so be sure to research and understand them before placing your order.
QuantitySpecify the number of shares you want to buy or sell
DurationIndicate the duration for which your order will be active. You can choose from options like "Day" (valid only for the current trading day) or "Good 'til Canceled" (valid until you manually cancel the order)
After entering the necessary information, review your order carefully to ensure it reflects your intentions accurately. When you are ready, submit your order by clicking the "Submit," "Place Order," or equivalent button. Your brokerage firm will then execute your order according to your instructions, subject to market conditions and the availability of shares. Keep in mind that market orders may be executed immediately, while limit orders, stop orders, and stop-limit orders will only be executed if the specified conditions are met. Finally, monitor your order status and confirm its execution. You can usually find this information in the "Order History" or "Order Status" section of your brokerage account.

Monitor your Janux Stock position

Monitoring your stock positions with your brokerage involves regularly checking the status and performance of your investments. Here's how you can monitor your stock positions using your brokerage account: First, access your account by signing in to your brokerage firm's website or mobile app using your login credentials. Once you're logged in, look for the section that displays your account information and portfolio holdings. This section may be labeled as "Portfolio," "Positions," "Holdings," or something similar. In this section, you'll generally find a list of the stocks and other investments that you own, along with relevant details such as the number of shares, the current market value, and the percentage change in value since the last trading day's close. You might also see the total cost of your investment, your current profit or loss, and the percentage gain or loss. Many brokerages also provide tools and features that allow you to analyze and track your stock positions more effectively. These may include:
Performance ChartsThese charts visually represent the historical price movement of your stocks over different time frames. You can use them to assess the trends and volatility of your investments.
Stock AlertsYou can set up custom alerts to receive notifications when a stock reaches a certain price, percentage change, or other criteria. This can help you stay informed about significant market movements affecting your investments.
WatchlistsCreate watchlists to track the performance of stocks you are interested in but have not yet purchased. This can help you identify potential opportunities or risks.
Research ToolsBrokerages often provide access to research tools, such as stock screeners, analyst reports, and financial statements, to help you make more informed investment decisions.
As you continue to monitor your Janux Stock position, remember that in order to be an effective trader, it is critical to understand your entire portfolio's sensitivity to market volatility and how your single Janux Therapeutics position affects your overall exposure to market risk. One of the techniques to manage your overall risk is pair trading, a market-neutral trading strategy enabling traders to profit from virtually any market condition, whether it is experiencing an uptrend or downtrend movement.

Moving together with Janux Stock

  0.83CDIOW Cardio DiagnosticsPairCorr
  0.82ELVN Enliven Therapeutics Downward RallyPairCorr
  0.85SCLX Scilex HoldingPairCorr
  0.87ASMB Assembly Biosciences Earnings Call TomorrowPairCorr
  0.88CDIO Cardio DiagnosticsPairCorr
  0.94CRNX Crinetics PharmaceuticalsPairCorr

Moving against Janux Stock

  0.87WM Waste ManagementPairCorr
  0.84LUCD Lucid DiagnosticsPairCorr
  0.81GE GE AerospacePairCorr
  0.69PLX Protalix BiotherapeuticsPairCorr
  0.43PG Procter GamblePairCorr
It's a good idea to monitor your stock positions regularly to ensure that your investments align with your financial goals and risk tolerance. Keep in mind that the stock market can be volatile, and it's essential to maintain a long-term perspective when evaluating your portfolio's performance.

Follow Janux Stock across various news and media outlets

Far too much social signal, news, headlines, and media speculation about Janux Therapeutics that are available to investors today. That information is available publicly through Janux media outlets and privately through word of mouth or via Janux internal channels. However, regardless of the origin, that massive amount of Janux data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Janux Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Janux Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Janux Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Janux Therapeutics alpha.